420 related articles for article (PubMed ID: 18096344)
1. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
Weininger M; Lauterbach B; Knop S; Pabst T; Kenn W; Hahn D; Beissert M
Eur J Radiol; 2009 Feb; 69(2):339-45. PubMed ID: 18096344
[TBL] [Abstract][Full Text] [Related]
2. [Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results].
Schmidt GP; Baur A; Stäbler A; Schoenberg SO; Steinborn M; Baltin V; Reiser MF
Rofo; 2005 May; 177(5):745-50. PubMed ID: 15871089
[TBL] [Abstract][Full Text] [Related]
3. [Abdominal and pelvic segmented T1-weighted echo-planar imaging and MRI. Comparison with T1-TSE and T2-UTSE sequences].
Maubon A; Berger V; Aubas P; Ferru JM; Rouanet JP
J Radiol; 1999 Mar; 80(3):291-6. PubMed ID: 10327336
[TBL] [Abstract][Full Text] [Related]
4. MRI of the thorax during whole-body MRI: evaluation of different MR sequences and comparison to thoracic multidetector computed tomography (MDCT).
Frericks BB; Meyer BC; Martus P; Wendt M; Wolf KJ; Wacker F
J Magn Reson Imaging; 2008 Mar; 27(3):538-45. PubMed ID: 18224677
[TBL] [Abstract][Full Text] [Related]
5. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging as a supplement for the clinical staging system of Durie and Salmon?
Baur A; Stäbler A; Nagel D; Lamerz R; Bartl R; Hiller E; Wendtner C; Bachner F; Reiser M
Cancer; 2002 Sep; 95(6):1334-45. PubMed ID: 12216103
[TBL] [Abstract][Full Text] [Related]
7. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study.
Schmidt GP; Wintersperger B; Graser A; Baur-Melnyk A; Reiser MF; Schoenberg SO
Invest Radiol; 2007 Jun; 42(6):449-59. PubMed ID: 17507818
[TBL] [Abstract][Full Text] [Related]
8. In vivo biochemical 7.0 Tesla magnetic resonance: preliminary results of dGEMRIC, zonal T2, and T2* mapping of articular cartilage.
Welsch GH; Mamisch TC; Hughes T; Zilkens C; Quirbach S; Scheffler K; Kraff O; Schweitzer ME; Szomolanyi P; Trattnig S
Invest Radiol; 2008 Sep; 43(9):619-26. PubMed ID: 18708855
[TBL] [Abstract][Full Text] [Related]
9. [Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns].
Baur A; Stäbler A; Steinborn M; Schnarkowski P; Pistitsch C; Lamerz R; Bartl R; Reiser M
Rofo; 1998 Apr; 168(4):323-9. PubMed ID: 9589093
[TBL] [Abstract][Full Text] [Related]
10. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
[TBL] [Abstract][Full Text] [Related]
12. MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis.
Hosch W; Bock M; Libicher M; Ley S; Hegenbart U; Dengler TJ; Katus HA; Kauczor HU; Kauffmann GW; Kristen AV
Invest Radiol; 2007 Sep; 42(9):636-42. PubMed ID: 17700279
[TBL] [Abstract][Full Text] [Related]
13. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV
J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
[TBL] [Abstract][Full Text] [Related]
14. Whole-body T2* mapping at 1.5 T.
Rossi C; Boss A; Haap M; Martirosian P; Claussen CD; Schick F
Magn Reson Imaging; 2009 May; 27(4):489-96. PubMed ID: 18814986
[TBL] [Abstract][Full Text] [Related]
15. Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
Fayed N; Morales H; Modrego PJ; Pina MA
Acad Radiol; 2006 Jun; 13(6):728-37. PubMed ID: 16679275
[TBL] [Abstract][Full Text] [Related]
16. T1-weighted-SPACE dark blood whole body magnetic resonance angiography (DB-WBMRA): initial experience.
Mihai G; Chung YC; Merchant A; Simonetti OP; Rajagopalan S
J Magn Reson Imaging; 2010 Feb; 31(2):502-9. PubMed ID: 20099365
[TBL] [Abstract][Full Text] [Related]
17. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
18. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
20. Reproducibility and repeatability of volumetric measurements for olfactory bulb volumetry: which method is appropriate? An update using 3 Tesla MRI.
Burmeister HP; Baltzer PA; Möslein C; Bitter T; Gudziol H; Dietzel M; Guntinas-Lichius O; Kaiser WA
Acad Radiol; 2011 Jul; 18(7):842-9. PubMed ID: 21669350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]